SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Galectin Therapeutics Reports September 30, 2026 Financial Results and Provides Business Update

NORCROSS, Ga., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. NASDAQ:GALT, the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a business update for the three months ended September 30, 2026.“New analyses were presented a…

GALT

Related stories